Samsung Invests in China’s Phrontline Biopharma via Life Science Fund
Samsung invests in China’s Phrontline Biopharma via its Life Science Fund, targeting next-generation ADC cancer therapies and expanding global biotech partnerships.
Curogen, a South Korean biotech, has recruited top global investors and drug development experts to its board as it accelerates US market expansion, marking a major step in its global growth strategy.
#YonhapInfomax #Curogen #USMarket #BiotechInvestment #DrugDevelopment #BoardAppointment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=66044
Curogen Bolsters Global Leadership with Top Biotech Investors and Drug Development Experts to Target US Market
Curogen, a South Korean biotech, has recruited top global investors and drug development experts to its board as it accelerates US market expansion, marking a major step in its global growth strategy.
Kim Byung-hwan Visits US Biotech Cluster - 'Will Utilize Advanced Strategic Fund to Boost Investment'
FSC Chairman Kim Byung-hwan explores biotech investment boost through Advanced Strategic Fund during US visit, emphasizing public-private synergy and ecosystem support amid global market challenges.
Ministry of Industry Rolls Up Sleeves to Support Investment Attraction for Promising Biotech Companies
MOTIE hosts investment presentation for biotech firms, aiming to boost sector growth and attract private capital amid industry's high investment needs
DB Asset Management's Lee Ju-kyung, a biotech specialist, discusses industry trends, investment strategies, and the future of biohealth care sector, highlighting opportunities in cancer treatments, obesity drugs, and new modalities.
#YonhapInfomax #BiohealthcareSector #DBAssetManagement #BiotechInvestment #CancerTreatments #NewModalities #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=51363
Yonhap Infomax News